Glypican 3-specific Chimeric Antigen Receptor Expressed in T Cells for Patients With Pediatric Solid Tumors (GAP)
Clinical trial NCT02932956 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT02932956
- Sponsor
- Baylor College of Medicine
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-12-17
- Primary completion
- 2021-09-27
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.